Main content
'Not too late to review cost' of breast cancer drug Kadcyla
The NHS has rejected a drug that can extend lives of women with breast cancer because it is 鈥榯oo expensive鈥�. Jennifer Cozzone head of Health Economics and Pricing at Roche and Mia Rosenblatt from Breast Cancer Campaign discuss.
Duration:
This clip is from
Featured in...
![]()
Health clips
Listen to a selection of clips from recent and upcoming programmes.
More clips from Today
-
![]()
Early release scheme frees hundreds more prisoners today
Duration: 02:24
-
![]()
Riyadh airport hit by second Houthi strike in two days
Duration: 03:36
-
![]()
Polanski under pressure after Zionism row & by-election loss
Duration: 05:17
-
![]()
Firing squad execution to be livestreamed, Pentagon says
Duration: 03:10
